跳至主要内容
临床试验/IRCT201312031414N30
IRCT201312031414N30已完成4 期

Evaluation of Satisfaction and Short-term Side effect after OsteoCalVitFort Practice in population whom use Calcium Supplement

pharmedshayan pharmaceutical0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
All

入选标准

  • Age between 45 to 70 years old who received Calcium supplement; In good health, as determined by the principal investigator based on medical history and physical examination; Clinical laboratory evaluations within the reference range for the test laboratory; Ability to comprehend and willingness to sign the Informed Consent Form for this study.
  • Exclusion criteria:
  • Clinically complicated biochemical tests; Any diagnosed malignancy; Any drug hypersensitivity; History of kidney stone; hyperparathyroidism or sarcoidosis; unwilling to participation.

排除标准

  • 未提供

研究者

发起方
pharmedshayan pharmaceutical

相似试验